Kitai Junya, Minoda Sada Ryuichi, Yamaguchi Satoko, Shinde Akiyo, Maruyama Wataru
Department of General Internal Medicine, Tenri Hospital, Japan.
Department of Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan.
Intern Med. 2025 Apr 15;64(8):1267-1274. doi: 10.2169/internalmedicine.3817-24. Epub 2024 Sep 4.
A 58-year-old Japanese woman with rheumatoid arthritis (RA) presented with the sudden onset of cognitive dysfunction. A random skin biopsy revealed intravascular large B-cell lymphoma (IVLBCL), which resolved spontaneously with methotrexate withdrawal. However, four months later, the disease relapsed with liver injury. After completion of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy, both RA and IVLBCL remained in remission for two years. Among the pathological subtypes of RA-associated lymphoproliferative diseases, reports on IVLBCL are limited, and little is known about its clinical course. Our literature review summarizes the clinical course and mortality of 11 patients with RA-IVLBCL.
一名58岁的日本类风湿关节炎(RA)女性患者出现了突发的认知功能障碍。随机皮肤活检显示为血管内大B细胞淋巴瘤(IVLBCL),停用甲氨蝶呤后该淋巴瘤自发缓解。然而,四个月后,疾病复发并伴有肝损伤。在完成利妥昔单抗、环磷酰胺、多柔比星、长春新碱和泼尼松龙治疗后,RA和IVLBCL均缓解了两年。在RA相关淋巴增殖性疾病的病理亚型中,关于IVLBCL的报道有限,对其临床病程了解甚少。我们的文献综述总结了11例RA-IVLBCL患者的临床病程和死亡率。